April 22, 2018

Teva shares dive after Q2 miss

05 August 2017, 12:30 | Lionel James

Teva Pharmaceutical Industries Limited - TEVA - Stock Price Today - Zacks - Zacks Investment Research

Teva Pharmaceutical Industries wears a shirt bearing the company's logo at its Jerusalem oral solid dosage plant

Several other research analysts have also issued reports on TEVA. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges. Cantor Fitzgerald set a $31.00 target price on Teva Pharmaceutical Industries Limited and gave the company a "hold" rating in a research report on Thursday, June 22nd. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has "Equal Weight" rating given on Tuesday, January 31 by Barclays Capital. BTIG Research restated a neutral rating on shares of Teva Pharmaceutical Industries in a research note on Thursday, April 6th. (NYSE:CYT), 1 have Buy rating, 0 Sell and 4 Hold. Bronfman E.L. Rothschild L.P. now owns 3,617 shares of the company's stock valued at $116,000 after buying an additional 261 shares during the period.

It is now trading at $23.75 marginally under the 50 day moving average which is $32.05 and which is just a bit below the 200 day moving average of $32.28. The stock has a market capitalization of $24.13 billion, a price-to-earnings ratio of 304.49 and a beta of 0.46. The 7 months bearish chart indicates high risk for the $23.97 billion company. National Pension Service raised its position in Teva Pharmaceutical Industries Limited by 15.6% in the second quarter. Stock investors acquired 66,716 put options on the company. This represents an increase of approximately 864% compared to the typical volume of 6,922 put options.

Teva Pharmaceutical Industries Limited (NYSE:TEVA)'s stock on Thursday traded at beginning with a price of $25.75 and when day-trade ended the stock finally moved down -24.00% to reach at $23.75.

Teva also missed estimates when it came to earnings per share.

Teva Pharmaceutical Industries Limited (TEVA)'s ROE is 0.27%, while industry's is 17.14%. "Non-GAAP EPS for 2017 is now expected to be $4.30 - $4.50, based on a weighted average number of shares of 1,076 million, down from a previously expected range of $4.90 - $5.30". The company's revenue was up 12.9% compared to the same quarter previous year. Equities analysts anticipate that Teva Pharmaceutical Industries Limited will post $4.65 earnings per share for the current year.

Fla. Reports 1st Case of Sexually Transmitted Zika Virus This Year
The majority of the 118 reported cases of Zika infection in Florida during 2017 have been related to travel to infected areas. Officials want to warn the public to take precautions if you or your partner traveled to an area where Zika is active.

WARNING: This piece of content was reported by Sports Perspectives and is the property of of Sports Perspectives. The correct version of this piece of content can be accessed at Excluding share-based remuneration for employees and acquisition of R&D, R&D expenses totaled $450 million in the second quarter of 2017, 7.9% of revenue, compared with $370 million, 7.3% of revenue in the second quarter of 2016.

The company's share price is now down 11 percent on the Tel Aviv Stock Exchange and 10 percent on the New York Stock Exchange.

Global sales of Teva's best-selling multiple sclerosis drug Copaxone fell 10 percent in the quarter to $1.02 billion. Migdal Insurance & Financial Holdings Ltd. increased its position in Teva Pharmaceutical Industries by 21.3% in the fourth quarter. Its pivot point high generated sell signal on Wednesday July 26, 2017, which calls for additional declines until the stock forms a new pivot point low, as this could be a buying opportunity.

Teva Pharmaceutical took on debt to acquire the Actavis generic drug business from Allergan. "We have made important progress and it has been positive so far", he said, also deflecting questions from analysts on the prospects of splitting the company into two - generics and specialty drugs.

Other News

Trending Now

Caixin China Manufacturing PMI Reaches Five-Month High in July
The data was in contrast to the official PMI on Monday, which came in at 51.4, below the expected 51.6. The Caixin PMI rose to stand at 51.1 for the month of July, compared to the 50.4 figure seen in June .

Month may hold highest gas prices
Today, South Carolina continues to register the lowest average in the nation at $2.02, followed by Alabama at $2.03. Gasoline prices in MA have shot up 3 cents for the second straight week as slumping gas prices appear to be over.

US Diplomatic Staff Begins Withdrawing From Russia
Peskov said the reduction of diplomatic staff ordered by Putin could include Russian Federation citizens. The story of the USA sanctions showed that the Kremlin no able to make any dvuhhodovki.

Donald Trump's police brutality comments 'making a joke' - White House
Last month, Trump's eldest son insisted that his 2016 meeting with the pro-Kremlin lawyer was about adoption of Russian children. Mr Trump Jr later revealed he had agreed to meet her after being told he could receive damaging material on Hillary Clinton .

Beijing hits back at Trump criticism over N Korea
North Korea first demonstrated its nuclear abilities on October 9, 2006, when they conducted their first underground nuclear test. Abe said: "International society, including Russian Federation and China, need to take this seriously and increase pressure".

'Dukes of Hazzard' star arrested in Waltham on indecent assault, drug charges
The City of Waltham Police Department was unable to comment on Wopat's arrest when reached by the Daily News. A once-over of the vehicle uncovered a baggie of cocaine, which resulted in a possession charge.

No life without parole in Hawaii for those younger than 18
Since the rulings, OR has resentenced one man who had been given life without parole for a killing committed as a youth. Juveniles can still be sentenced to long prison terms as a result of serious crimes or multiple charges.

IOS: Microsoft Kills Word Flow Keyboard-Here's What to Replace It With
Microsoft is clearly focusing more on SwiftKey and supporting two independent smartphone keyboard projects doesn't make sense. Industry giant Microsoft on Monday announced the removal of Windows phone keyboard from its app store.

China to Trump: stop with the "emotional venting" on Twitter
There is no getting away from the fact that China can and should do more to pressure the North to curb its nuclear program. Suggestions that the United States could force a regime change in North Korea have also only further inflamed tensions.

Russian Federation to seize U.S. properties in retaliation over sanctions
The move came following United States lawmakers' decision to approve a new round of sanctions against Russian Federation. Russia's Foreign Ministry dismissed the new sanctions as "creating unfair competitive advantages for the USA economy".